| |
 |
|
Class Information
Number: 424/189.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Hepatitis virus
Description: Subject matter wherein the virus is a hepatitis virus.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7022830 |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
Apr. 4, 2006 |
| 6986892 |
Immunogenic Hepatitis C virus non-structural polypeptides |
Jan. 17, 2006 |
| 6964769 |
Molecular antigen array |
Nov. 15, 2005 |
| 6964852 |
Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection |
Nov. 15, 2005 |
| 6932972 |
Combined vaccine compositions |
Aug. 23, 2005 |
| 6930095 |
Hepatitis C virus constructs characterized by high efficiency replication |
Aug. 16, 2005 |
| 6921534 |
Hepatitis B virus treatment |
Jul. 26, 2005 |
| 6919203 |
Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
Jul. 19, 2005 |
| 6919318 |
Enhancing immune responses to genetic immunization by using a chemokine |
Jul. 19, 2005 |
| 6893644 |
Hepatitis vaccines containing 3-O-deacylated monophoshoryl lipid A |
May. 17, 2005 |
| 6887464 |
Advanced antigen presentation platform |
May. 3, 2005 |
| 6881821 |
Hepatitis-C virus type 4, 5, and 6 |
Apr. 19, 2005 |
| 6870043 |
Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4 positive T cells |
Mar. 22, 2005 |
| 6858590 |
Vaccines containing ribavirin and methods of use thereof |
Feb. 22, 2005 |
| 6855809 |
Methods for the simultaneous detection of HCV antigens and HCV antibodies |
Feb. 15, 2005 |
| 6855318 |
Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes |
Feb. 15, 2005 |
| 6827937 |
HBV capsid-binding peptide immunogens |
Dec. 7, 2004 |
| 6797809 |
Multiple fusion antigens for use in immunoassays for anti-HCV antibodies |
Sep. 28, 2004 |
| 6790445 |
Preservatives for vaccines |
Sep. 14, 2004 |
| 6787142 |
Mutant human hepatitis B viral strain and uses thereof |
Sep. 7, 2004 |
| 6787145 |
Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
Sep. 7, 2004 |
| 6740323 |
HBV/HCV virus-like particle |
May. 25, 2004 |
| 6706873 |
Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
Mar. 16, 2004 |
| 6689363 |
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
Feb. 10, 2004 |
| 6689368 |
Immunodominant human T-cell epitopes of hepatitis C virus |
Feb. 10, 2004 |
| 6685931 |
Treatment of hepatitis C virus infections with interleukin-10 |
Feb. 3, 2004 |
| 6685944 |
Modified HCV peptide vaccines |
Feb. 3, 2004 |
| 6680059 |
Vaccines containing ribavirin and methods of use thereof |
Jan. 20, 2004 |
| 6613333 |
Immunodominant human T-cell epitopes of hepatitis C virus |
Sep. 2, 2003 |
| 6592871 |
HCV peptide antigens and methods for the determination of HCV |
Jul. 15, 2003 |
| 6589534 |
Hepatitis B virus binding proteins and uses thereof |
Jul. 8, 2003 |
| 6589530 |
Hepatitis B surface antigen vaccine |
Jul. 8, 2003 |
| 6576240 |
Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection |
Jun. 10, 2003 |
| 6572864 |
Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines |
Jun. 3, 2003 |
| 6562346 |
Activation of HCV-specific T cells |
May. 13, 2003 |
| 6558675 |
Mutant human hepatitis B viral strain and uses thereof |
May. 6, 2003 |
| 6541210 |
Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
Apr. 1, 2003 |
| 6538123 |
Vaccine composition for preventing or treating hepatitis C |
Mar. 25, 2003 |
| 6514731 |
Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens |
Feb. 4, 2003 |
| 6475489 |
Synthesis of human virus antigens by yeast |
Nov. 5, 2002 |
| 6451320 |
Combined hepatitis and herpesvirus antigen compositions |
Sep. 17, 2002 |
| 6447992 |
Method for serological typing using type-specific antigens |
Sep. 10, 2002 |
| 6444210 |
Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity |
Sep. 3, 2002 |
| 6436402 |
Process for making human papillomavirus virus-like particles with improved properties |
Aug. 20, 2002 |
| 6432408 |
Swine hepatitis E virus and uses thereof |
Aug. 13, 2002 |
| 6428792 |
Hepatitis C virus multiple copy epitope fusion antigens |
Aug. 6, 2002 |
| 6410009 |
Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
Jun. 25, 2002 |
| 6403092 |
Immune response modulator alpha-2 macroglobulin complex |
Jun. 11, 2002 |
| 6379886 |
Diagnostic regeant for hepatitis C virus infection |
Apr. 30, 2002 |
| 6372883 |
Antiviral medicaments |
Apr. 16, 2002 |
|
|
|
